Please login to the form below

lenalidomide

This page shows the latest lenalidomide news and features for those working in and with pharma, biotech and healthcare.

GSK preps filings for BCMA-targeting multiple myeloma drug

lenalidomide), a proteasome inhibitor such as Takeda’s Velcade (bortezomib), as well as Johnson &Johnson’s anti-CD38 antibody Darzalex (daratumumab).

Latest news

BMS buoyed by FDA approval of Celgene’s myelofibrosis drug

The approval is the latest in a string of regulatory wins for Celgene, coming after approval of a combination of Revlimid (lenalidomide) and Roche’s Rituxan (rituximab) – known as the R2
Triplet approvals for myeloma boost Celgene in Q2

Sales came in at $4.40bn, with Revlimid (lenalidomide) once again making the largest contribution with an 11% increase to $2.73bn that Celgene said was the result of increased adoption ... Revlimid’s gains came despite the arrival the first
MorphoSys eyes 2020 launch for lymphoma CAR-T challenger

The phase 2 L-MIND study in diffuse large B-cell lymphoma (DLBCL) showed that the combination of tafasitamab with Celgene’s Revlimid (lenalidomide) had an overall response rate of 60%,
After discount row, NICE finally says yes to first line Revlimid

Meindert Boysen, director of the Centre for Health Technology Evaluation at NICE, said: “We are pleased to recommend lenalidomide for these patients.
BMS closes on Celgene merger after rebel investors bow out

Both shareholders have said they are concerned about Celgene’s reliance on blood cancer drug Revlimid (lenalidomide), which accounts for almost two-thirds of the company’s sales and is due

More from news
Approximately 14 fully matching, plus 90 partially matching documents found.

Latest Intelligence

European biotech: a new generation of leaders emerges

The phase 2 L-MIND study in diffuse large B-cell lymphoma (DLBCL) showed the combination of tafasitamab with Celgene’s Revlimid (lenalidomide) had an overall response rate of 60%, with
Building a business that is lean and specialised

drug Revlimid (lenalidomide).

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Senior Medical Writer – Medical Communications – North West – In...: Excellent Remuneration Package

Account Director, Medical Education: Salary TBC

Experienced / Senior Medical Writer - Excellent Progression Oppo...: Excellent Salary and Benefits on offer

Senior Medical Writer: Salary TBC

Senior Account Manager / Account Director - MedComms - London: Highly competitive salary &package

Editorial Assistants - Medical Communications agency - Cheshire: Excellent Remuneration Package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Senior / Principal Medical Writers wanted - MedComms - Various U...: Excellent Remuneration Packages

Senior Copywriter: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...